Visicol: profile and news

Salix Pharmaceuticals Reports 1Q2006 Results  May 4, 2006
VISICOL(R) generated revenue of $9.8 million for the first quarter of 2006, compared to $5.2 million a year ago when InKine was independent. ... - Genetic Engineering News,

FDA CAPSULES  May 16, 2006
Documented cases include patients who used a solution (such as Fleet Phospho-soda or Fleet Accu-Prep) or tablets (Visicol). NEW DRUG FOR BONE MARROW DISORDER. ... - Newsday,

Oral Sodium Phosphate (OSP) Products for Bowel Cleansing  May 9, 2006
...has been associated with the use of oral sodium phosphate (OSP) products (eg, Fleet Phospho-soda solution, Fleet Accu-Prep solution, and Visicol tablets) for ... - Food Consumer,

Non-liquid colonoscopy prep approved  Apr 25, 2006
Last year Salix Pharmaceuticals bought out Inkine Pharmaceuticals, which has produced a bowel cleansing prescription tablet, known as Visicol, for six years. ... - Newsday,

Bowel Cleansers Get FDA Warning  May 5, 2006
Of the cases, 21 involved patients given solutions such as Fleet Phospho-soda or Fleet Accu-Prep. One patient had taken Visicol tablets. ... - Los Angeles Times,

Salix Q1 EPS Rises On Surged Revenues, Yet Misses Estimates ...  May 4, 2006
...prior-year quarter. Revenues from VISICOL rose to $9.8 million from $5.2 million in the last year's quarter. The company forecasts ... - Trading Markets,

FDA alert focuses on bowel cleansers  May 5, 2006
One patient had taken Visicol tablets. The FDA says none of the cases involved a recently approved product called OsmoPrep tablets. - KTRE,

FDA Issues Warning on Bowel-Cleansing Products  May 5, 2006
Twenty-one of the cases involved patients given products such as Fleet Phospho-soda or Fleet Accu-Prep. One patient had taken Visicol tablets. ... - KPHO Phoenix,

Salix Pharmaceuticals Announces 1Q2006 Financial Results ...  Apr 20, 2006
Salix markets COLAZAL(R), XIFAXAN(R), VISICOL(R), OSMOPREP(TM), AZASAN(R), ANUSOL-HC(R) and PROCTOCORT(R). MOVIPREP(R) and granulated mesalamine are under ... - Genetic Engineering News,

Salix Announces Completion of OsmoPrep(TM) versus Liquid Bowel ...  Apr 19, 2006
Salix also markets COLAZAL(R) (balsalazide disodium) Capsules 750 mg, XIFAXAN(R) (rifaximin) tablets 200 mg, VISICOL(R) Tablets (sodium phosphate monobasic ... - Genetic Engineering News,